Patent Yard Sign in
Expired Canadian patentCanada

Production of human t-cell leukemia (lymphotropic) retrovirus (htlv-i) envelope protein fragments in bacteria and use in seroepidemiological survey of human lymphoid malignancies

CA 1340878 C · Owner: Samuel, Kenneth · Inventors: Papas, Takis S.; Samuel, Kenneth; Wong-Staal, Flossie

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Two regions of the gene for the HTLV-I envelope were expressed in Escherichia coli by use of the vector pJLAl6. One corresonds to the carboxy-terminal region of the major envelope protein p46 and the other corresponds to the transmembrane protein p2lE. Reactivity of the expressed protein with human sera was tested by Western blot procedure. Each of the sera tested that had been shown to contain anti-HTLV-I or anti-HTLV-II antibodies by ELISA assay recognized the bacterially synthesized envelope proteins. There was no reaction detected when control sera. were tested. This system is useful for large scale seroepidemiological surveys for this and related human retroviruses.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted January 25, 2000. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended January 25, 2017.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 15, 1985
GrantedJanuary 25, 2000
Term endedJanuary 25, 2017
Patent numberCA 1340878 C
Classification (IPC)C12N15/09 +2 more

Timeline

Timeline From CIPO dates

19861990199419982002200620102014Application filedOct 15, 1985Patent grantedJan 25, 2000Term endedJan 25, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.